BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10471042)

  • 1. Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.
    Coulson JM; Stanley J; Woll PJ
    Br J Cancer; 1999 Aug; 80(12):1935-44. PubMed ID: 10471042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upstream stimulatory factor activates the vasopressin promoter via multiple motifs, including a non-canonical E-box.
    Coulson JM; Edgson JL; Marshall-Jones ZV; Mulgrew R; Quinn JP; Woll PJ
    Biochem J; 2003 Feb; 369(Pt 3):549-61. PubMed ID: 12403649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arginine vasopressin promoter regulation is mediated by a neuron-restrictive silencer element in small cell lung cancer.
    Coulson JM; Fiskerstrand CE; Woll PJ; Quinn JP
    Cancer Res; 1999 Oct; 59(20):5123-7. PubMed ID: 10537286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.
    Coulson JM; Fiskerstrand CE; Woll PJ; Quinn JP
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):961-70. PubMed ID: 10585887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
    Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
    Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A splice variant of the neuron-restrictive silencer factor repressor is expressed in small cell lung cancer: a potential role in derepression of neuroendocrine genes and a useful clinical marker.
    Coulson JM; Edgson JL; Woll PJ; Quinn JP
    Cancer Res; 2000 Apr; 60(7):1840-4. PubMed ID: 10766169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron specific enolase promoter for suicide gene therapy in small cell lung carcinoma.
    Tanaka M; Inase N; Miyake S; Yoshizawa Y
    Anticancer Res; 2001; 21(1A):291-4. PubMed ID: 11299750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corin-mediated processing of pro-atrial natriuretic peptide in human small cell lung cancer cells.
    Wu F; Wu Q
    Cancer Res; 2003 Dec; 63(23):8318-22. PubMed ID: 14678991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
    Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
    Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of gene regulatory elements for selective gene expression in human melanoma cells.
    Artuc M; Nürnberg W; Czarnetzki BM; Schadendorf D
    Biochem Biophys Res Commun; 1995 Aug; 213(2):699-705. PubMed ID: 7646526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
    Lange C; Walther W; Schwabe H; Stein U
    Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter.
    Berry NB; Cho YM; Harrington MA; Williams SD; Foley J; Nephew KP
    Gynecol Oncol; 2004 Mar; 92(3):896-904. PubMed ID: 14984958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of the human myeloperoxidase promoter region.
    Chumakov AM; Chumakova EA; Chih D; Koeffler HP
    Int J Oncol; 2000 Feb; 16(2):401-11. PubMed ID: 10639585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
    Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
    Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.